Access cutting-edge ovarian cancer treatment through this clinical trial at a research site in Newport Beach. Study-provided care at no cost to qualified participants.
Access ovarian cancer specialists in Newport Beach at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ovarian cancer treatment provided free
This is phase 2 single arm study evaluating the safety and preliminary efficacy of M-CENK adoptive cell therapy and fixed dose of N-803 in combination with gemcitabine in participants with platinum-resistant high-grade ovarian cancer (HGOC).Up to 20 participants will receive M-CENK (IV) and N-803 (SC) in combination with gemcitabine (IV). Participants will undergo an apheresis procedure for the collection of mononuclear cells (MNCs) at least 1 day prior to Cycle 1 for manufacturing of M-CENK. S
Sponsor: ImmunityBio, Inc.
Check if you qualify for this ovarian cancer clinical trial in Newport Beach, CA
If you're searching for ovarian cancer treatment options in Newport Beach, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Newport Beach research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ovarian cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.